-
Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib
Clinical Lymphoma, Myeloma & Leukemia, 2020
-
Oprozomib, Pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical Lymphoma, Myeloma & Leukemia, 2019
-
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma
Clinical Lymphoma, Myeloma & Leukemia, 2019
-
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
The New England Journal of Medicine, 2019
-
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia, 2019
-
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
The New England Journal of Medicine, 2018
-
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data From Prospective Studies
The Oncologist, 2018
-
Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy
British Journal of Haematology, 2017
-
Safety and Efficacy of Romiplostim in Splenectomized and Nonsplenectomized Patients With Primary Immune Thrombocytopenia
Haematologica, 2017
-
Long-Term Treatment With Ruxolitinib for Patients With Myelofibrosis: 5-Year Update From the Randomized, Double-Blind, Placebo-Controlled, Phase 3 COMFORT-I Trial
Journal of Hematology & Oncology, 2017
-
Relation Between Chelation and Clinical Outcomes in Lower-Risk Patients With Myelodysplastic Syndromes: Registry Analysis at 5 Years
Leukemia Research, 2017
-
A Phase 2 Safety Study of Accelerated Elotuzumab Infusion, Over Less Than 1 H, in Combination With Lenalidomide and Dexamethasone, in Patients With Multiple Myeloma
American Journal of Hematology, 2017
-
The Efficacy and Safety of Continued Hydroxycarbamide Therapy Versus Switching to Ruxolitinib in Patients With Polycythaemia Vera: A Randomized, Double-Blind, Double-Dummy, Symptom Study (RELIEF)
British Journal of Haematology, 2017
-
Long-Term Treatment With Ruxolitinib for Patients With Myelofibrosis: 5-Year Update From the Randomized, Double-Blind, Placebo-Controlled, Phase 3 COMFORT-I Trial
Journal of Hematology and Oncology, 2017
-
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
The New England Journal of Medicine, 2017
-
Phase 2, Randomized, Double-Blind Study of Pracinostat in Combination With Azacitidine in Patients With Untreated, Higher-Risk Myelodysplastic Syndromes
Cancer, 2017
-
CHAMPION-1, a Phase I/II Study of Once-Weekly Carfilzomib With Dexamethasone for Relapsed or Refractory Multiple Myeloma
Blood, 2016
-
Edoxaban for Venous Thromboembolism in Patients With Cancer: Results From a Non-Inferiority Subgroup Analysis of the Hokusai-VTE Randomised, Double-Blind, Double-Dummy Trial
The Lancet Haematology, 2016
-
Efficacy, Safety and Survival With Ruxolitinib in Patients With Myelofibrosis: Results of a Median 3-Year Follow-Up of COMFORT-1
Haematologica, 2015
-
Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG
Case Reports in Hematology, 2015
-
Integrated Analysis of Long-Term Safety in Patients With Chronic Immune Thrombocytopaenia (ITP) Treated With the Thrombopoietin (TPO) Receptor Agonist Romiplostim
International Journal of Hematology, 2015
-
Updated Results From CHAMPION-1, a Phase I/II Study Investigating Weekly Carfilzomib With Dexamethasone for Patients (Pts) With Relapsed or Refractory Multiple Myeloma (RRMM)
Blood, 2015
-
Oprozomib, Pomalidomide, and Dexamethasone (OPomd) in Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Initial Results of a Phase 1b Study (NCT01999335)
Blood, 2015
-
A Randomized, Placebo-Controlled, Phase II Study of Pracinostat in Combination with Azacitidine (AZA) in Patients with Previously Untreated Myelodysplastic Syndrome (MDS)
Blood, 2015
-
Final Results of Anagrelide Controlled-Release (GALE-401) Safety, Efficacy and Pharmacokinetics in Subjects with Myeloproliferative Neoplasms
Blood, 2015
-
Safety and Tolerability of Eltrombopag Versus Placebo for Treatment of Thrombocytopenia in Patients With Advanced Myelodysplastic Syndromes or Acute Myeloid Leukaemia: A Multicentre, Randomised, Placebo-Controlled, Double-Blind, Phase 1/2 Trial
The Lancet Haematology, 2015
-
Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin
JAMA Internal Medicine, 2014
-
Oral Rivaroxaban Versus Enoxaparin with Vitamin K Antagonist for the Treatment of Symptomatic Venous, Thromboembolism in Patients with Cancer (EINSTEIN-DVT and EINSTEIN-PE): a Pooled Subgroup Analysis of Two Randomised Controlled Trials
The Lancet Haematology, 2014
-
Relationship Between Chelation and Clinical Outcomes in Lower-Risk Patients with Myelodysplastic Syndrome (MDS): Registry Analysis at 5 Years
Blood, 2014
-
The Efficacy and Safety of Continued Hydroxyurea Therapy Versus Switching to Ruxolitinib in Patients with Polycythemia Vera: A Randomized, Double-Blind, Double-Dummy, Symptom Study (RELIEF)
Blood, 2014
-
Iron Overload, Chelation Therapy and Survival in Lower-risk Myelodysplastic Syndromes: State of Evidence
International Blood Research & Reviews, 2014
-
Comparison of 24-Month Outcomes in Chelated and non-Chelated Lower-risk Patients with Myelodysplastic Syndromes in a Prospective Registry
Leukemia Research, 2014
-
Comparison of Placebo and Best Available Therapy for the Treatment of Myelofibrosis in the Phase 3 COMFORT Studies
Haematologica, 2013
-
Efficacy, Safety and Survival with Ruxolitinib Treatment in Patients with Myelofibrosis: Results of a Median 2-year Follow-up of COMFORT-1
Haematologica, 2013
-
Self-Administration of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP)
Community Oncology, 2013
-
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-controlled, Phase III Study in Patients with Myelofibrosis
British Journal of Haematology, 2013
-
Placebo-controlled, Randomized, Phase I/II Trial of the Thrombopoeitin Receptor Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia
18th Congress of the European Hematology Association, 2013
-
Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP): Safety and Efficacy
British Journal of Haematology, 2013
-
Interim Analysis of Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Count
Journal of Hematology & Oncology, 2013
-
Edoxaban Versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
The New England Journal of Medicine, 2013
-
48-Month Update on Survival and AML Transformation in a 600-Patient Registry of Lower-Risk MDS Patients
Blood, 2013
-
Randomized, Placebo-Controlled, Phase I/II Trial of the Thrombopoietin Receptor (TPO-R) Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia—A Subgroup Analysis of Patients Receiving Concomitant Anticancer Therapy
Blood, 2013
-
Edoxaban for Long-term Treatment of Venous Thromboembolism in Cancer Patients
Blood, 2013
-
Long-Term Outcomes of Ruxolitinib Therapy in Patients With Myelofibrosis: 3-Year Update From COMFORT-1
Blood, 2013
-
The VIP (Very Immunocompromised Patient) Protocol: Improved Access to Care and Time to Antibiotics
Blood, 2013
-
Mature Response Data From a Phase 2 Study of PI3K-Delta Inhibitor Idelalisib In Patients With Double (Rituximab and Alkylating Agent)-Refractory Indolent B-Cell Non-Hodgkin Lymphoma (iNHL).
Blood, 2013
-
Outpatient Consolidation Treatment with Clofarabine in a Phase 2 Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML)
Leukemia and Lymphoma, 2012
-
Myelodysplastic Syndromes: Therapy and Outlook
American Journal of Medicine, 2012
-
Phase 1 Dose-ranging Study of Ezatiostat Hydrochloride in Combination with Lenalidomide in Patients with Non-deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Journal of Hematology & Oncology, 2012
-
Long-Term Outcome of Ruxolitinib Treatment in Patients with Myelofibrosis: Durable Reductions in Spleen Volume, Improvements in Quality of Life, and Overall Survival Advantage in COMFORT-1
54th Annual Meeting of the American Society of Hematology, 2012
-
Preliminary Safety and Efficacy of Ruxolitinib in Patients with Primary and Secondary Myelofibrosis with Platelet Counts of 50-100x10^9L
Journal of Clinical Oncology, 2012
-
A Randomized, Double-blind, Placebo-controlled Phase 2 Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome Receiving Lenalidomide
Journal of Hematology & Oncology, 2012
-
A Double-Blind Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
The New England Journal of Medicine, 2012
-
Oral Ezatiostat HCl (Telintra, TLK199) and Idiopathic Chronic Neutropenia (ICN): A Case Report of Complete Response of a Patient with G-CSF Resistant ICN Following Treatment with Ezatiostat, a Glutathionie S-transferase P1-1 (GSTP1-1) Inhibitor
Journal of Hematology & Oncology, 2011
-
Update of an Open-Label Extension Study Evaluating the Long-Term Safety & Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes
Leukemia Research, 2011
-
Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study
Blood, 2011
-
Outpatient Consolidation Treatment with Clofarabine in a Phase 2 Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML)
Leukemia and Lymphoma, 2011
-
A Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia
Investigational New Drugs, 2011
-
Oral Ezatiostat HCl (Telintra, TLK 199) and Idiopathic Chronic Neutropenia (ICN): A Case Report of Complete Response of a Patient with G-CSF Resistant ICN Following Treatment with Ezatiostat, a Glutathione S-transferase P1-1 (GSTP1-1) Inhibitor
Journal of Hematology & Oncology, 2011
-
Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults with Acute Myeloid Leukemia and Unfavorable Prognostic Factors
Journal of Clinical Oncology, 2010
-
Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma
Blood, 2010
-
Safety and Efficacy of Romiplostim in Patient with Lower-risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia
Journal of Clinical Oncology, 2010
-
Improved Quality of Life for Romiplostim-Treated Patients with Chronic Immune Thormbocytopenic Purpura: Results from Two Randomized, Placebo-Controlled Trials
British Journal of Haematology, 2009
-
Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes
Journal of Clinical Oncology, 2009
-
Treatment Selection for Myelodysplastic Syndrome Patients in a Community Setting
Clinical Advances in Hematology & Oncology, 2009
-
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP
Blood, 2009
-
Choosing the Appropriate Therapy for Lower-risk MDS in the Community Setting
Clinical Advances in Hematology & Oncology, 2009
-
Choosing the Appropriate Therapy for Lower-risk MDS in the Community Setting
Clinical Advances in Hematology & Oncology, 2009
-
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP
Blood, 2008
-
Recent Advances in Low- and Intermediate-1--Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy
Clinical Advances in Hematology & Oncology, 2008
-
Phase 2, Single-arm, Trial to Evaluate the Effectiveness of Darbopoetin alfa for Correcting Anaemia in Patients with Myelodysplastic Syndromes
British Journal of Haematology, 2008
-
Efficacy of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura: a Double-blind Randomised Controlled Trial
Lancet, 2008
-
Recent Advances in Low- and Intermediate-1—Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy
Clinical Advances in Hematology & Oncology, 2008
-
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes
Cancer, 2007
-
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes
Cancer, 2007
-
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP
New England Journal of Medicine, 2006
-
Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period
Clinical and Applied Thrombosis/Hemostasis, 2006
-
Low Dose Vitamin K to Augment Anticoagulation Control
Pharmacotherapy, 2005
-
Initial Management of Immune Thrombocytopenic Purpura in Adults: A Randomized Controlled Trial Comparing Intermittent Anti-D With Routine Care
American Journal of Hematology, 2003
-
Evidence-Based Review of Tinzaparin Sodium and Guidelines for Administration
Clinical Advances in Hematology & Oncology, 2003
-
Controversies in Antithrombotic Therapy for Patients With Mechanical Heart Valves
Pharmacotherapy, 1998
-
Acetominophen and Risk Factors for Excess Anticoagulation With Warfarin
JAMA, 1998
-
Comparing Different Routes and Doses of Phytonadione for Reversing Excessive Anticoagulation
Archives of Internal Medicine, 1998
-
Efficacy & Safety of Enoxaparin for Prevention of Deep Venous Thrombosis After Hip Replacement Surgery: Enoxaparin Clinical Trial Group
Annals of Internal Medicine, 1994
-
Phase I Trial of Dacarbazine With Cyclophosphamide, Carmustine, Etoposide, and Autologous Stem-Cell Transplantation in Patients With Lymphoma and Multiple Myeloma
Journal of Clinical Oncology, 1994
-
An Abnormal Plasminogen With a More Cathodic Migration: Decreased Activation and Associated Thrombosis
Thrombosis and Hemostasis, 1988
-
Thrombolytic Therapy for Coronary Artery Thrombosis
Bexar County Medical News, 1988
-
Requirements for Different Ca2+ Pools in the Activation of Rabbit Platelets: I. Release Reaction and Protein Phosphorylation
Biochimica et Biophysica Acta, 1982
-
Extra and Intracellular Ca2+ Requirements for Lysosomal Enzyme Secretion in Human Neutrophils
Agents and Actions, 1982
-
Interaction of Ca2+ and Protein Phosphorylation in the Rabbit Platelet Release Reaction
Journal of Clinical Investigation, 1980
-
Compartmentalization of Adenosine 3′: 5″ –Monophosphate – Binding Proteins in Human Platelets
Thrombosis Research, 1980
-
Characterization of a Platelet Protein Phosphorylated During the Thrombin Induced Release Reaction
Biochemistry, 1979
-
Rheumatoid Factor Interference With the Latex Agglutination Test for Fibrin Degradation Products
Journal of Laboratory and Clinical Medicine, 1978
-
Development of Chronic Myelocytic Leukemia During the Course of Acute Lymphocytic Leukemia in an Adult
American Journal of Hematology, 1977
-
Efficacy and Safety of Low Molecular Weight Heparin (Ardeparin Sodium) Compared to Warfarin for the Prevention of Venous Thromboembolism After Total Knee Replacement Surgery; a Double-Blind, Dose-Ranging Study. Ardeparin Arthroplasty Study Group
Thrombosis and Haemostatsis, 1977
-
Gamma Heavy Chain Disease: Rapid, Sustained Response to Cyclophosphamide and Prednisone
Blood, 1975
-
Thrombin-Induced Protein Phosphorylation in Human Platelets
Journal of Clinical Investigation, 1975
-
Active Transport of Nitrogen Mustard and Choline by Normal and Leukemic Human Lymphoid Cells
Cancer Research, 1972
-
Sensitivity to Nitrogen Mustard as a Function of Transports Activity and Proliferative Rate in L5178Y Lymphoblasts
Cancer Research, 1971